pdf
Published
2022-01-24
Issue
Section
Pharmacy Practice & Practice-Based Research
Categories
License
Copyright (c) 2022 Melody Okereke
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
The State of Pharmaceutical Manufacturing in the Democratic Republic of Congo: The Journey so Far
Melody Okereke
Faculty of Pharmaceutical Sciences, University of Ilorin, Kwara State, Nigeria
DOI: https://doi.org/10.24926/iip.v13i1.4466
Keywords: DRC, Congo, Pharmaceutical, Manufacturing, COVID-19, Drug Importation
Abstract
Despite a population of over 89 million people, the Democratic Republic of Congo (DRC) has just 30 local pharmaceutical manufacturers (DRC) with the majority of manufacturers based in Kinshasa, the capital city. Of the total number of pharmaceutical products sold in the DRC, just 10% accounts for those manufactured locally. The DRC remains dependent on other countries such as China and India for the supply of active pharmaceutical ingredients (APIs) -thus, local pharmaceutical manufacturing is therefore reliant on imported commodities and industrial machinery. Given the relevance of the pharmaceutical industry, it is vital to pay careful attention to the problems affecting it. Here, we assess the current situation of pharmaceutical manufacturing in the DRC, examine current challenges, and provide solutions for future development.
